Share page with colleagues
Archives
Blog Archives
Adaptive Partners with BMS on Cancer Immunotherapy Program
Today, Adaptive announced a partnership with Bristol Myers Squibb for the discovery of immunological biomarkers in cancer. The announcement was even picked up by the Wall Street Journal, whose press release can be read here. BMS is a pioneer and … Continue reading
View similar posts in Announcements, News, Newsworthy, Press Release
Story of Emma Whitehead’s ALL Remission Making Multiple Headlines
The media is on fire with the news. Emma Whitehead, according to Adaptive customer Dr. Stephen Grupp, “is in complete remission. She has no leukemia in her body by any tests we can do, even the most sensitive tests…” The … Continue reading
View similar posts in Announcements, News, Newsworthy
Adaptive, working with scientists at the University of Pennsylvania, show that ‘In Girl’s Last Hope, Altered Immune Cells Beat Leukemia’
It’s been a big week for Adaptive with the American Society of Hematology (ASH), which concluded today. We announced the new ClonoSEQ service, we had a new, larger exhibitor booth (#2433), and had many talks and posters highlighting our work … Continue reading
View similar posts in Announcements, Food for Thought, News, Newsworthy
Genetic Sequencing Combats Leukemia
An interesting article about the use of genetic sequencing to treat leukemia appeared this past summer in the New York Times. It describes how a leukemia researcher at Washington University in St. Louis found out that he had the very … Continue reading
View similar posts in Food for Thought, Newsworthy
Another Sign of Promise of Personalized Medicine
There was an interesting news article recently in the New York Times on a story related to treating a rare cancer using personalized medicine. It was both an encouraging and a heart-breaking story. A patient had been diagnosed with a … Continue reading
View similar posts in Newsworthy
Adaptive Biotechnologies makes front page of GenomeWeb!
We’ve done it again! Our newest publication, “High-Throughput Sequencing Detects Minimal Residual Disease in Acute T Lymphoblastic Leukemia”, published this morning in Science Translational Medicine, continues to make headlines. Although you must be a registered user of GenomeWeb to view the … Continue reading
View similar posts in Announcements, News, Newsworthy
Adaptive Biotechnologies makes front page of Xconomy!
With the release of another scientific paper, Adaptive Biotechnologies was featured this morning as a top news story for Xconomy Seattle- click here to read the article, titled “Hutch, UW Scientists Find Elusive Cancers With Adaptive Diagnostic”. The paper, “High-Throughput Sequencing Detects … Continue reading
View similar posts in News, Newsworthy
Coming Soon… BetaSEQ: Spectratyping, BetaMark, and Clonotyping all in one reaction
In the near future, Adaptive Biotechnologies will launch a new assay, BetaSEQ, allowing clients to compare high-throughput sequencing data to previously generated spectratyping, V usage, and clonotyping data sets. Here is a sneak peek at a few of the analysis tools that … Continue reading
View similar posts in Announcements, Assays, Newsworthy
Discovery of Memory Stem T cells
An article published in Nature Medicine by Luca Gattinoni et al. suggests that a new subset of T lymphocytes, memory stem T cells (TSCM cells), may exist. Not only does this newly characterized subset of T cells exhibit stem cell-like … Continue reading
View similar posts in Newsworthy
Measuring T cells in Solid Tumors: Potential Applications
Our last post discussed the ability of the ImmunoSEQ platform to sequence T- and B-cells from tissues such as solid tumors. Today, we’d like to share a paper that was recently presented at Adaptive’s weekly journal club and provides an … Continue reading
View similar posts in Newsworthy
